SHL1 Stock Overview
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Siemens Healthineers AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €26.00 |
| 52 Week High | €28.40 |
| 52 Week Low | €22.00 |
| Beta | 0.73 |
| 1 Month Change | -0.76% |
| 3 Month Change | -4.41% |
| 1 Year Change | 3.17% |
| 3 Year Change | 7.44% |
| 5 Year Change | 40.54% |
| Change since IPO | 36.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHL1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.7% | -6.4% | -1.8% |
| 1Y | 3.2% | -3.1% | 1.7% |
Return vs Industry: SHL1 exceeded the German Medical Equipment industry which returned -3.1% over the past year.
Return vs Market: SHL1 exceeded the German Market which returned 1.7% over the past year.
Price Volatility
| SHL1 volatility | |
|---|---|
| SHL1 Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: SHL1 has not had significant price volatility in the past 3 months.
Volatility Over Time: SHL1's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 71,400 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
| SHL1 fundamental statistics | |
|---|---|
| Market cap | €58.51b |
| Earnings (TTM) | €1.84b |
| Revenue (TTM) | €21.87b |
31.8x
P/E Ratio2.7x
P/S RatioIs SHL1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHL1 income statement (TTM) | |
|---|---|
| Revenue | €21.87b |
| Cost of Revenue | €13.67b |
| Gross Profit | €8.20b |
| Other Expenses | €6.36b |
| Earnings | €1.84b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
| Earnings per share (EPS) | 1.65 |
| Gross Margin | 37.50% |
| Net Profit Margin | 8.41% |
| Debt/Equity Ratio | 76.4% |
How did SHL1 perform over the long term?
See historical performance and comparison